Russia Sleep Aids Market Outlook

russia is one of the leading markets in terms of sleep aids. this has been largely due to the increasing prevalence of sleep-related disorders, such as insomnia and sleep apnea, as the number of people suffering from them continues to rise. in addition, the presence of a large elderly population and population with chronic diseases has also contributed towards the growth of the russian sleep aids market. in terms of product types, the market is classified into over-the-counter (otc) and prescription drugs. the otc segment held the dominant share in 2018 and is expected to retain its dominance over the forecast period, owing to the growing preference for otc medications. moreover, the presence of a variety of otc products, such as sleeping pills, supplements, etc. also support the growth of the segment. in 2018, the retail pharmacy segment held the largest share of the sleep aids market in russia due to the increased presence and availability of products. online pharmacies and drugstores are also expected to witness a significant growth rate over the forecast period, owing to the convenience of online delivery and increasing penetration of e-commerce in the region. in terms of region, russia is categorized as the central and eastern europe region and is expected to witness a healthy cagr during the forecast period. rising incidence of sleep related disorders, increasing geriatric population, and growing awareness about insurance policies have been major factors that are expected to drive the market growth over the forecast period. the competitive landscape of the russian sleep aids market is highly fragmented due to the presence of a number of local and international players. major companies operating in the russian sleep aids market include mitsubishi tanabe pharma, teva pharmaceutical industries ltd., sanofi, alpharma, merck group, glaxosmithkline plc, pfizer, mylan laboratories, and astrazeneca. overall, the russia sleep aids market is expected to witness a healthy growth over the forecast period due to the increasing prevalence of sleep-related disorders, rising geriatric population, and government initiatives.